中国药业2013，Vol.22Issue(9)：7-8,2.
美沙拉嗪联合双歧三联活菌治疗重度溃疡性结肠炎的疗效评价
Efficacy for Mesalazine Combined with Tri-Bifidobacteria in Treatment of Severe Ulcerative Colitis
李小平1
作者信息
- 1. 宁波大学医学院附属鄞州医院消化科,浙江台州 315040
- 折叠
摘要
Abstract
Objective To discuss the clinical effect of mesalazine combined with tri-bifidobacteria in the treatment of severe ulcerative colitis.Methods 120 cases of severe ulcerative colitis patients from in our hospital were randomly divided into two groups.The observation group took the treatment regimen of mesalazine combined with tri-bifidobacteria,while the control group was given only mesalazine.Results The cure rate and the total effective rate in the observation group were significantly higher than those in the control group,the differences between the two groups showing statistical significance (P ＜ 0.05).The effective rate in the observation group of 94.8％ was significantly higher than the control group of 90.3％.The serum C-reactive protein levels in patients had a significantly decreasing.The serum level of C-reactive protein after treatment in the observation group was significantly decreased compared with the control group,indicating that the improving situation of inflammation in the observation group was significantly better than that in the control group with statistical difference between the two groups (P ＜ 0.05).Conclusion Mesalazine combined with tri-bifidobacteria is significantly effective in the treatment of severe ulcerative colitis.关键词
美沙拉嗪/双歧三联活菌/溃疡性结肠炎Key words
mesalazine/ probiotics/ tri-bifidobacteria分类
医药卫生引用本文复制引用
李小平..美沙拉嗪联合双歧三联活菌治疗重度溃疡性结肠炎的疗效评价[J].中国药业,2013,22(9):7-8,2.
